奥精医疗
(688613)
| 流通市值：22.41亿 | | | 总市值：22.41亿 |
| 流通股本：1.37亿 | | | 总股本：1.37亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 42,459,701.13 | 206,033,014.77 | 148,311,250.58 | 100,240,888.1 |
| 营业收入 | 42,459,701.13 | 206,033,014.77 | 148,311,250.58 | 100,240,888.1 |
| 二、营业总成本 | 46,643,863.61 | 225,153,067.35 | 155,366,595.73 | 102,413,305.12 |
| 营业成本 | 16,683,324.46 | 59,600,685.73 | 37,883,215.86 | 23,320,799.07 |
| 税金及附加 | 1,112,060.98 | 3,574,003.19 | 2,605,581.75 | 1,844,526 |
| 销售费用 | 8,687,709.79 | 48,001,433.24 | 29,413,832.57 | 20,121,171.11 |
| 管理费用 | 14,405,225.28 | 75,597,292.33 | 61,832,042.95 | 41,847,177.06 |
| 研发费用 | 5,146,405.26 | 38,767,871.53 | 24,366,528.85 | 16,732,657.88 |
| 财务费用 | 609,137.84 | -388,218.67 | -734,606.25 | -1,453,026 |
| 其中:利息费用 | - | 2,946,041.75 | 2,169,411 | 1,455,422.98 |
| 其中:利息收入 | - | 3,498,926.17 | -3,126,124.85 | -3,084,110.44 |
| 加:公允价值变动收益 | 3,592,200.94 | 6,350,717.03 | 2,543,421.55 | 8,109,817.61 |
| 加:投资收益 | 8,999.1 | 11,564,831.6 | 13,606,668.52 | 411,537.05 |
| 资产处置收益 | 201,189.53 | 637,448.22 | 643,911.25 | 747,528.78 |
| 资产减值损失(新) | - | 201,283.84 | - | - |
| 信用减值损失(新) | 475.49 | -9,234,516.71 | -2,097,027.55 | -2,105,863.27 |
| 其他收益 | 188,882.73 | 2,239,391.14 | 293,569.96 | 289,634.16 |
| 营业利润平衡项目 | 0.01 | 0 | 0 | 0 |
| 四、营业利润 | -192,414.68 | -7,360,897.46 | 7,935,198.58 | 5,280,237.31 |
| 加:营业外收入 | - | 84,821.24 | 0.94 | 0.94 |
| 减:营业外支出 | 294.35 | 1,660,328.75 | 1,501,035.66 | 164,910.93 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | -192,709.03 | -8,936,404.97 | 6,434,163.86 | 5,115,327.32 |
| 减:所得税费用 | - | 8,202,626.03 | 7,244,663.64 | 172,318.28 |
| 六、净利润 | -192,709.03 | -17,139,031 | -810,499.78 | 4,943,009.04 |
| 持续经营净利润 | -192,709.03 | -17,139,031 | -810,499.78 | 4,943,009.04 |
| 归属于母公司股东的净利润 | 1,041,517.76 | -12,662,162.69 | 4,888,240.36 | 9,222,057.43 |
| 少数股东损益 | -1,234,226.79 | -4,476,868.31 | -5,698,740.14 | -4,279,048.39 |
| (一)基本每股收益 | 0.01 | -0.09 | 0.04 | 0.07 |
| (二)稀释每股收益 | 0.01 | -0.09 | 0.04 | 0.07 |
| 八、其他综合收益 | 280,869.33 | -293,775.12 | 25,125.05 | -3,814.7 |
| 归属于母公司股东的其他综合收益 | 280,869.33 | -293,775.12 | 25,125.05 | -3,814.7 |
| 九、综合收益总额 | 88,160.3 | -17,432,806.12 | -785,374.73 | 4,939,194.34 |
| 归属于母公司股东的综合收益总额 | 1,322,387.09 | -12,955,937.81 | 4,913,365.41 | 9,218,242.73 |
| 归属于少数股东的综合收益总额 | -1,234,226.79 | -4,476,868.31 | -5,698,740.14 | -4,279,048.39 |
| 公告日期 | 2025-04-26 | 2025-04-26 | 2024-10-29 | 2024-08-27 |
| 审计意见(境内) | | 标准无保留意见 | | |